According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.38. In 2022 the company made an earnings per share (EPS) of -$1.37 a decrease over its 2021 EPS that were of -$1.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.38 | 0.73% |
2022 | -$1.37 | 17.39% |
2021 | -$1.17 | 50.85% |
2020 | -$0.77 |